These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 25759055

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. An update on the clinical pharmacokinetics of fexofenadine enantiomers.
    Akamine Y, Miura M.
    Expert Opin Drug Metab Toxicol; 2018 Apr; 14(4):429-434. PubMed ID: 29635947
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical pharmacokinetics of fexofenadine enantiomers.
    Miura M, Uno T.
    Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):69-74. PubMed ID: 19947891
    [Abstract] [Full Text] [Related]

  • 5. Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers.
    Akamine Y, Miura M, Yasui-Furukori N, Ieiri I, Uno T.
    J Clin Pharm Ther; 2015 Feb; 40(1):98-103. PubMed ID: 25263393
    [Abstract] [Full Text] [Related]

  • 6. Influence of drug-transporter polymorphisms on the pharmacokinetics of fexofenadine enantiomers.
    Akamine Y, Miura M, Sunagawa S, Kagaya H, Yasui-Furukori N, Uno T.
    Xenobiotica; 2010 Nov; 40(11):782-9. PubMed ID: 20839930
    [Abstract] [Full Text] [Related]

  • 7. The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion.
    Akamine Y, Miura M, Komori H, Tamai I, Ieiri I, Yasui-Furukori N, Uno T.
    Drug Metab Pharmacokinet; 2015 Oct; 30(5):352-7. PubMed ID: 26213156
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of fexofenadine enantiomers in healthy subjects.
    Miura M, Uno T, Tateishi T, Suzuki T.
    Chirality; 2007 Mar; 19(3):223-7. PubMed ID: 17230498
    [Abstract] [Full Text] [Related]

  • 9. Enantioselective uptake of fexofenadine by Caco-2 cells as model intestinal epithelial cells.
    Togami K, Tosaki Y, Chono S, Morimoto K, Hayasaka M, Tada H.
    J Pharm Pharmacol; 2013 Jan; 65(1):22-9. PubMed ID: 23215684
    [Abstract] [Full Text] [Related]

  • 10. Chiral Transplacental Pharmacokinetics of Fexofenadine: Impact of P-Glycoprotein Inhibitor Fluoxetine Using the Human Placental Perfusion Model.
    Pinto L, Bapat P, de Lima Moreira F, Lubetsky A, de Carvalho Cavalli R, Berger H, Lanchote VL, Koren G.
    Pharm Res; 2021 Apr; 38(4):647-655. PubMed ID: 33825113
    [Abstract] [Full Text] [Related]

  • 11. The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers.
    Tateishi T, Miura M, Suzuki T, Uno T.
    Br J Clin Pharmacol; 2008 May; 65(5):693-700. PubMed ID: 18294330
    [Abstract] [Full Text] [Related]

  • 12. The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans.
    Imanaga J, Kotegawa T, Imai H, Tsutsumi K, Yoshizato T, Ohyama T, Shirasaka Y, Tamai I, Tateishi T, Ohashi K.
    Pharmacogenet Genomics; 2011 Feb; 21(2):84-93. PubMed ID: 21280267
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.
    Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ, Kim RB.
    Clin Pharmacol Ther; 2002 Jan; 71(1):11-20. PubMed ID: 11823753
    [Abstract] [Full Text] [Related]

  • 15. Vectorial transport of fexofenadine across Caco-2 cells: involvement of apical uptake and basolateral efflux transporters.
    Ming X, Knight BM, Thakker DR.
    Mol Pharm; 2011 Oct 03; 8(5):1677-86. PubMed ID: 21780830
    [Abstract] [Full Text] [Related]

  • 16. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine.
    Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB.
    Drug Metab Dispos; 1999 Aug 03; 27(8):866-71. PubMed ID: 10421612
    [Abstract] [Full Text] [Related]

  • 17. Effect of fruit juices on the oral bioavailability of fexofenadine in rats.
    Kamath AV, Yao M, Zhang Y, Chong S.
    J Pharm Sci; 2005 Feb 03; 94(2):233-9. PubMed ID: 15570603
    [Abstract] [Full Text] [Related]

  • 18. Stereoselectivity of chiral drug transport: a focus on enantiomer-transporter interaction.
    Zhou Q, Yu LS, Zeng S.
    Drug Metab Rev; 2014 Aug 03; 46(3):283-90. PubMed ID: 24796860
    [Abstract] [Full Text] [Related]

  • 19. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides.
    Dresser GK, Kim RB, Bailey DG.
    Clin Pharmacol Ther; 2005 Mar 03; 77(3):170-7. PubMed ID: 15735611
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of fexofenadine following LPS administration to rats.
    Jaisue S, Gerber JP, Davey AK.
    Xenobiotica; 2010 Nov 03; 40(11):743-50. PubMed ID: 20863200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.